Seite - (000398) - in Biomedical Chemistry: Current Trends and Developments

Caminschi, I., Proietto, A. I., Ahmet, F., et al. (2008). The dendritic cell subtype-restricted c-type lectin clec9a is a target for vaccine enhancement. Blood, 112(8), 3264-3273. Carmeliet, P., Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407(6801), 249-257. Chandramohan, V., Mitchell, D. A., Johnson, L. A., et al. (2013). Antibody, t-cell and dendritic cell immunotherapy for malignant brain tumors. Future Oncology, 9(7), 977-990. Chandrasekhar, P., Shahid-Mohammad, S., Debnath, S., et al. (2013). A review on latest trends in oncho nanotechnology. International Journal of Pharmaceutical Development and Technology, 3(2), 106-109. Chen, C. Y., Huang, D., Yao, S., et al. (2012). Il-2 simultaneously expands foxp3+ t regulatory and t effector cells and confers resistance to severe tuberculosis (tb): Implicative treg-t effector cooperation in immunity to tb. Journal of Immunology, 188(9), 4278-4288. Chen, Z. Y., Wang, Y. X., Lin, Y., et al. (2014). Advance of molecular imaging technology and targeted imaging agent in imaging and therapy. Biomed Research International, 2014, 819324. Chenevier, P., Grandjean, C., Loing, E., et al. (2002). Grafting of synthetic mannose receptor- ligands onto onion vectors for human dendritic cells targeting. Chemical Communications (Camb)(20), 2446-2447. Cheng, K., Peng, S., Xu, C., et al. (2009). Porous hollow fe3o4 nanoparticles for targeted delivery and controlled release of cisplatin. Journal of American Chemical Society, 131(30), 10637- 10644. Cheng, L., Anglin, E., Cunin, F., et al. (2008). Intravitreal properties of porous silicon photonic crystals: A potential self-reporting intraocular drug-delivery vehicle. British Journal of Ophthalmology, 92(5), 705-711. Cho, K. J., Wang, X., Nie, S. M., et al. (2008). Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Research, 14(5), 1310-1316. Choi, K. Y., Liu, G., Lee, S., (2012). Theranostic nanoplatforms for simultaneous cancer imaging and therapy: Current approaches and future perspectives. Nanoscale, 4(2), 330-342. Chuan, X., Song, Q., Lin, J., et al. (2014). Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: Synthesis, characterization, and antitumor activity in vitro and in vivo. Molecular Pharmaceutics, 11(10), 3656-3670. Cohen, S., Alonso, M. J., Langer, R. (1994). Novel approaches to controlled-release antigen delivery. International Journal of Technology Assessment in Health Care, 10(1), 121-130. Coosemans, A., Tuyaerts, S., Vanderstraeten, A., et al. (2014). Dendritic cell immunotherapy in uterine cancer. Human Vaccines & Immunotherapeutics, 10(7), 1822-1827. Corot, C., Robert, P., Idee, J. M., et al. (2006). Recent advances in iron oxide nanocrystal technology for medical imaging. Advanced Drug Delivery Reviews, 58(14), 1471-1504. Correia-Pinto, J. F., Csaba, N., Alonso, M. J. (2013). Vaccine delivery carriers: Insights and future perspectives. International Journal of Pharmaceutics, 440(1), 27-38. Coti, K. K., Belowich, M. E., Liong, M., et al. (2009). Mechanised nanoparticles for drug delivery. Nanoscale, 1(1), 16-39. Couvreur, P., Vauthier, C. (2006). Nanotechnology: Intelligent design to treat complex disease. Pharmaceutical Research, 23(7), 1417-1450.